<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE nitf SYSTEM "http://www.nitf.org/IPTC/NITF/3.3/specification/dtd/nitf-3-3.dtd">
<nitf change.date="June 10, 2005" change.time="19:30" version="-//IPTC//DTD NITF 3.3//EN">
  <head>
    <title>IN BRIEF</title>
    <meta content="08BBIZ$03" name="slug"/>
    <meta content="8" name="publication_day_of_month"/>
    <meta content="10" name="publication_month"/>
    <meta content="2000" name="publication_year"/>
    <meta content="Sunday" name="publication_day_of_week"/>
    <meta content="Long Island Weekly Desk" name="dsk"/>
    <meta content="8" name="print_page_number"/>
    <meta content="14LI" name="print_section"/>
    <meta content="1" name="print_column"/>
    <meta content="Technology; Science; New York and Region" name="online_sections"/>
    <docdata>
      <doc-id id-string="1236974"/>
      <doc.copyright holder="The New York Times" year="2000"/>
      <identified-content>
        <classifier class="indexing_service" type="descriptor">Science and Technology</classifier>
        <classifier class="indexing_service" type="descriptor">Ratings and Rating Systems</classifier>
        <org class="indexing_service">American Biogenetic Sciences Inc</org>
        <person class="indexing_service">Deloitte &amp; Touche</person>
        <person class="indexing_service">Strugatch, Warren</person>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/New York and Region</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/New York and Region/Long Island</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/Science</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/Technology</classifier>
        <classifier class="online_producer" type="general_descriptor">Science and Technology</classifier>
        <classifier class="online_producer" type="general_descriptor">Ratings and Rating Systems</classifier>
      </identified-content>
    </docdata>
    <pubdata date.publication="20001008T000000" ex-ref="http://query.nytimes.com/gst/fullpage.html?res=9F04EED61E3DF93BA35753C1A9669C8B63" item-length="382" name="The New York Times" unit-of-measure="word"/>
  </head>
  <body>
    <body.head>
      <hedline>
        <hl1>IN BRIEF</hl1>
      </hedline>
      <byline class="print_byline">Compiled by Warren Strugatch</byline>
      <byline class="normalized_byline">Strugatch, Warren</byline>
      <abstract>
        <p>Deloitte &amp; Touche competition ranks American Biogenetic Sciences Inc of Copiague as first among Long Island's technology innovators (S)</p>
      </abstract>
    </body.head>
    <body.content>
      <block class="lead_paragraph">
        <p>A Copiague Company Tops 'Tech Fast 50' List</p>
        <p>American Biogenetic Sciences Inc. (Nasdaq: SC) has been ranked first among Long Island's technology innovators in a competition organized by Deloitte &amp; Touche.</p>
      </block>
      <block class="full_text">
        <p>A Copiague Company Tops 'Tech Fast 50' List</p>
        <p>American Biogenetic Sciences Inc. (Nasdaq: SC) has been ranked first among Long Island's technology innovators in a competition organized by Deloitte &amp; Touche.</p>
        <p>A.B.S., which is in Copiague, was recognized for its initiatives in drug development and medical technology, and the company has shown a five-year growth rate of 1,046 percent, Deloitte &amp; Touche said.</p>
        <p>The competition, known as the Long Island Technology Fast 50, is conducted annually by Deloitte and Touche's regional headquarters in Jericho.</p>
        <p>A.B.S. researches and develops diagnostic tests for cardiopulmonary conditions and infectious diseases, as well as new treatments for neurological disorders including epilepsy, migraine, well as new treatments for neurological disorders including epilepsy, migraine, Parkinson's disease and Alzheimer's disease. Revenues for 1999 were $1.4 million.</p>
        <p>In January, A.B.S. signed an exclusive licensing agreement with Abbott Laboratories to develop and market ABS-103, its compound for treating central nervous system disorders.</p>
        <p>First Industrial Agrees To Sell L.I. Portfolio</p>
        <p>First Industrial Realty Trust Inc. (NYSE: FR) of Chicago plans to sell the majority of its Long Island portfolio, probably before the end of the year. The company would not name the buyer nor the terms of the contract.</p>
        <p>First Industrial owns about 50 buildings representing 3.5 million square feet on Long Island. The company said the move was part of a realignment of its national portfolio, which totals about 77 million square feet.</p>
        <p>North Fork Ends Bid To Take Over Dime</p>
        <p>The North Fork Bancorporation of Melville decided that it would not extend its exchange offer for Dime Bancorp stock, an offer that expired on Sept. 29.</p>
        <p>The expiration effectively ended North Fork's seven-month-long hostile bid for Dime, a New York savings and loan, but North Fork planned to continue to seek control of Dime's board of directors.</p>
        <p>Compiled by Warren Strugatch</p>
        <p>E-mail: libiz@nytimes.com</p>
      </block>
    </body.content>
    <body.end>
      <tagline class="author_info">E-mail: libiz@nytimes.com</tagline>
    </body.end>
  </body>
</nitf>
